CN103960663A - Health care food for enhancing immunologic function and preparation method of food - Google Patents
Health care food for enhancing immunologic function and preparation method of food Download PDFInfo
- Publication number
- CN103960663A CN103960663A CN201410203602.7A CN201410203602A CN103960663A CN 103960663 A CN103960663 A CN 103960663A CN 201410203602 A CN201410203602 A CN 201410203602A CN 103960663 A CN103960663 A CN 103960663A
- Authority
- CN
- China
- Prior art keywords
- liquid
- health food
- solid
- preparation
- mouse
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000036737 immune function Effects 0.000 title claims abstract description 34
- 238000002360 preparation method Methods 0.000 title claims abstract description 23
- 235000013305 food Nutrition 0.000 title abstract description 12
- 230000002708 enhancing effect Effects 0.000 title abstract description 11
- 230000036541 health Effects 0.000 title abstract description 9
- 241000830535 Ligustrum lucidum Species 0.000 claims abstract description 40
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 38
- 240000005373 Panax quinquefolius Species 0.000 claims abstract description 33
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 32
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 239000007788 liquid Substances 0.000 claims description 55
- 235000013402 health food Nutrition 0.000 claims description 53
- 239000009636 Huang Qi Substances 0.000 claims description 29
- 238000005728 strengthening Methods 0.000 claims description 21
- 239000011812 mixed powder Substances 0.000 claims description 19
- 238000000926 separation method Methods 0.000 claims description 19
- 239000007787 solid Substances 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 239000008155 medical solution Substances 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 5
- 238000010298 pulverizing process Methods 0.000 claims description 5
- 238000009472 formulation Methods 0.000 claims description 4
- 239000002245 particle Substances 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- 238000005303 weighing Methods 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 2
- 238000005507 spraying Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 44
- 235000006533 astragalus Nutrition 0.000 abstract description 10
- 208000033065 inborn errors of immunity Diseases 0.000 abstract description 4
- 208000028529 primary immunodeficiency disease Diseases 0.000 abstract description 4
- 241000045403 Astragalus propinquus Species 0.000 abstract description 3
- 235000018142 Hedysarum alpinum var americanum Nutrition 0.000 abstract 1
- 240000006461 Hedysarum alpinum var. americanum Species 0.000 abstract 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 71
- 230000036039 immunity Effects 0.000 description 24
- 210000004698 lymphocyte Anatomy 0.000 description 24
- 150000004676 glycans Chemical class 0.000 description 23
- 229920001282 polysaccharide Polymers 0.000 description 23
- 239000005017 polysaccharide Substances 0.000 description 23
- 210000000952 spleen Anatomy 0.000 description 21
- 241000699670 Mus sp. Species 0.000 description 20
- 230000006870 function Effects 0.000 description 18
- 239000013642 negative control Substances 0.000 description 18
- 210000004027 cell Anatomy 0.000 description 16
- 239000000463 material Substances 0.000 description 16
- 230000000242 pagocytic effect Effects 0.000 description 16
- 238000002474 experimental method Methods 0.000 description 15
- 238000011160 research Methods 0.000 description 13
- 230000001900 immune effect Effects 0.000 description 11
- 210000001541 thymus gland Anatomy 0.000 description 11
- 210000001744 T-lymphocyte Anatomy 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 10
- 239000003814 drug Substances 0.000 description 10
- 241000202807 Glycyrrhiza Species 0.000 description 9
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 9
- 210000002540 macrophage Anatomy 0.000 description 9
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 8
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 8
- 229940010454 licorice Drugs 0.000 description 8
- 210000000056 organ Anatomy 0.000 description 8
- 210000002966 serum Anatomy 0.000 description 8
- 241001061264 Astragalus Species 0.000 description 7
- 241000545442 Radix Species 0.000 description 7
- 230000037396 body weight Effects 0.000 description 7
- 210000003024 peritoneal macrophage Anatomy 0.000 description 7
- 210000004233 talus Anatomy 0.000 description 7
- 235000019640 taste Nutrition 0.000 description 7
- 206010020751 Hypersensitivity Diseases 0.000 description 6
- 208000026935 allergic disease Diseases 0.000 description 6
- 230000003111 delayed effect Effects 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 210000001616 monocyte Anatomy 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 230000035755 proliferation Effects 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- 108010002350 Interleukin-2 Proteins 0.000 description 5
- 102000000588 Interleukin-2 Human genes 0.000 description 5
- 230000007815 allergy Effects 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 210000003743 erythrocyte Anatomy 0.000 description 5
- 238000003304 gavage Methods 0.000 description 5
- 239000003228 hemolysin Substances 0.000 description 5
- 229940088597 hormone Drugs 0.000 description 5
- 239000005556 hormone Substances 0.000 description 5
- 210000000987 immune system Anatomy 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 5
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 4
- 241000287828 Gallus gallus Species 0.000 description 4
- 108010006464 Hemolysin Proteins Proteins 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 230000002950 deficient Effects 0.000 description 4
- 230000000857 drug effect Effects 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 230000000527 lymphocytic effect Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 239000004378 Glycyrrhizin Substances 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 229940107628 american ginseng root Drugs 0.000 description 3
- 210000003719 b-lymphocyte Anatomy 0.000 description 3
- 210000001185 bone marrow Anatomy 0.000 description 3
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 3
- 229960004949 glycyrrhizic acid Drugs 0.000 description 3
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 3
- 235000019410 glycyrrhizin Nutrition 0.000 description 3
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 3
- 230000007365 immunoregulation Effects 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 210000004493 neutrocyte Anatomy 0.000 description 3
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 3
- 229930182490 saponin Natural products 0.000 description 3
- 150000007949 saponins Chemical class 0.000 description 3
- 230000003393 splenic effect Effects 0.000 description 3
- 230000004936 stimulating effect Effects 0.000 description 3
- 230000007306 turnover Effects 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 2
- 102100037850 Interferon gamma Human genes 0.000 description 2
- 108010074328 Interferon-gamma Proteins 0.000 description 2
- 241000699660 Mus musculus Species 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 206010057249 Phagocytosis Diseases 0.000 description 2
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 239000006286 aqueous extract Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 230000007969 cellular immunity Effects 0.000 description 2
- 206010008118 cerebral infarction Diseases 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 231100000673 dose–response relationship Toxicity 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000004727 humoral immunity Effects 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 235000021374 legumes Nutrition 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 239000002075 main ingredient Substances 0.000 description 2
- 210000000822 natural killer cell Anatomy 0.000 description 2
- 238000011580 nude mouse model Methods 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 230000008782 phagocytosis Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000002893 slag Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 108010001857 Cell Surface Receptors Proteins 0.000 description 1
- 108010062580 Concanavalin A Proteins 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 206010014025 Ear swelling Diseases 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 206010069767 H1N1 influenza Diseases 0.000 description 1
- 206010019617 Henoch-Schonlein purpura Diseases 0.000 description 1
- 208000031814 IgA Vasculitis Diseases 0.000 description 1
- 206010061598 Immunodeficiency Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 108010002352 Interleukin-1 Proteins 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 229920001491 Lentinan Polymers 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 206010029164 Nephrotic syndrome Diseases 0.000 description 1
- 206010029379 Neutrophilia Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010057863 Selective IgG subclass deficiency Diseases 0.000 description 1
- 230000006052 T cell proliferation Effects 0.000 description 1
- 210000000662 T-lymphocyte subset Anatomy 0.000 description 1
- 210000000447 Th1 cell Anatomy 0.000 description 1
- 210000004241 Th2 cell Anatomy 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000001919 adrenal effect Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000005875 antibody response Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000001640 apoptogenic effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 206010064097 avian influenza Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000022534 cell killing Effects 0.000 description 1
- 230000003399 chemotactic effect Effects 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 1
- 210000004443 dendritic cell Anatomy 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 208000024908 graft versus host disease Diseases 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 230000035931 haemagglutination Effects 0.000 description 1
- 230000009083 hemolysis by symbiont of host erythrocytes Effects 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000002766 immunoenhancing effect Effects 0.000 description 1
- 208000015446 immunoglobulin a vasculitis Diseases 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000016507 interphase Effects 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 description 1
- 229940115286 lentinan Drugs 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 102000006240 membrane receptors Human genes 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 239000003226 mitogen Substances 0.000 description 1
- 230000000394 mitotic effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 239000003726 plant lectin Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 201000010740 swine influenza Diseases 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 230000002992 thymic effect Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to the field of food health care, and particularly relates to a health care food for enhancing an immunologic function and a preparation method of the food. The health care food for enhancing the immunologic function comprises the following raw materials in parts by weight of 50-100 parts of astragalus membranaceus, 50-100 parts of glossy privet fruit, 5-50 parts of American ginseng and 5-50 parts of liquorice root. The health care food for enhancing the immunologic function, provided by the embodiment of the invention has an effect of enhancing the immunologic function of a human body; all raw materials can be used in a formula of a health care food, and are high in safety, and thus a product produced according to the formula is suitable for the crowds suffering from hypoimmunity, and is capable of enhancing the immunologic function of the human body with few side effects.
Description
Technical field
The present invention relates to health care of food field, in particular to a kind of for strengthening health food of immunologic function and preparation method thereof.
Background technology
With the quickening pace of modern life, from the pressure of society, work, life each side, allow people think that immunity is much worse than in the past, add bird flu, H1N1 influenza virus and import the special germ of China from Europe into, all the time all threatening people's health, people more and more recognize that improving immunity means and have healthy physique.And the immunity of body is carried out by immune system.Immune system is born three basic functions: immune protection, immunological homeostasis, immunosurveillance.
Once immunologic dysfunction, body just there will be corresponding disease.The development that clinical and experiment immunization is learned proves, infect, allergic disease, autoimmunity disease, tumour and aids (AIDS) etc. all with function of immune system normally whether have a close relationship.
Immune system comprises immune organ, immunocyte and immune molecule.Can get rid of specifically or non-specifically the foreign matter of invading body.Immunocyte mainly comprises T and bone-marrow-derived lymphocyte, monokaryon or macrophage, BMDC, acidophilia and basophilla polymorphonuclear cell, red blood cell and blood platelet; Immune organ comprises liver, spleen, lymph node, thymus gland, marrow etc.The development condition of immunocyte and immuning tissue, organ directly has influence on the height of immunity of organisms.Immune system is more perfect for identification, activation and effector cell's interphase interaction of specific immune response obtain, and is covered with all tissues of whole body.The height of immunity of organisms directly affects its premunition.
But, in the prior art, especially, in health care of food field, yet there are no the relevant report of the health food with immune enhancing function.Therefore,, for people's immunity is provided, providing a kind of is this area technical problem urgently to be resolved hurrily for strengthening the health food of immunologic function.
Summary of the invention
The object of the present invention is to provide a kind of for strengthening the health food of immunologic function, to solve the above problems.
It is a kind of above-mentioned for strengthening the preparation method of health food of immunologic function that another object of the present invention is to provide.
Provide in an embodiment of the present invention a kind of for strengthening the health food of immunologic function, according to weighing scale, its raw material components comprises:
Radix Astragali 50-100 part, fruit of glossy privet 50-100 part, American Ginseng 5-50 part, Radix Glycyrrhizae 5-50 part.
The embodiment of the present invention provide for strengthening the health food of immunologic function, its select Radix Astragali, the fruit of glossy privet, American Ginseng, Radix Glycyrrhizae four traditional Chinese medicine material by set parts by weight forms; In traditional Chinese medical science field, the Radix Astragali (Astragali Radix) is the dry root of legume astragalus mongolicus Astragalusmembranaceus (Fisch.) Bge.var.MonghoJicus (Bge.) Hsiao and Astragalus membranacus Astragalus membranaceus (Fisch.) Bge..First appeared in the unearthed book copied on silk in tomb of Han dynasty Mawangdui " 52 Bingfang ", Shennong's Herbal is classified as top grade.Bright Compendium of Material Medica carry " over sixty years of age is long also, Radix Astragali look Huang, for benefit person's length therefore named ... ".Property sweet, tepor, return lung, the spleen channel, have tonifying Qi and lifting yang, strengthening exterior and reducing sweat, inducing diuresis for removing edema, promotes the production of body fluid and nourishes blood, row stagnant logical numbness, detoxification apocenosis, the function of expelling pus and promoting granulation.In the history that reaches more than 2000 year, the Radix Astragali is used as the good medicine of enhancement ability and resist the disease in China.Modern pharmacological research shows: the Radix Astragali has sure immunological enhancement, non-specific and specific immunity are had to certain humidification, comprise and strengthen dendritic cells and cytophagous phagocytosis, raising NK cytoactive and lethal effect, adjusting cytokine content, increase T cell quantity and activity etc.In addition, there are some researches show, the Radix Astragali is observed to the impact on Turnover of Mouse Peritoneal Macrophages phagocytic activity with various dose, different approaches administration, find that there is enhancing in various degree, and can alleviate dexamethasone inhibitory action.Research is by the relatively discovery to peritoneal effluent macrophage phagocytic ability, and Radix Astragali group is apparently higher than control group.Scholar's research discovery, the Radix Astragali can raise the expression of endothelial cell surface adhesion molecule-I, strengthens the adhesion of neutrophil leucocyte and vascular endothelial cell, promotes the chemotactic of neutrophil leucocyte to areas of inflammation.After normal mouse gavages the Radix Astragali, its thymus gland significantly increases weight, and other every immune indexes all significantly improve as spleen index, phagocytic rate, phagocytic index, T cell proliferation.In addition, correlative study also shows, the Radix Astragali can promote the expression of IL-2mRNA in lymphocyte, reduce the inhibition of suppressor T lymphocyte (Ts) to lymphocyte IL-2mRNA, and induce IFN-γ, the preliminary treatment results of infant anaphylactoid purpura is shown to the Radix Astragali is improved the effect of Th1 cell factor, reduces the effect of Th2 cell factor simultaneously in addition.The researchs such as Tan Feng show, after quiet Astragalus in Treating of acute cerebral infarction patients, survey CD3, CD4+, CD4+/CD8+ level significantly increase compared with control group, CD8+ level obviously lowers, show to exist after Cerebral Infarction lymphocyte immunologic function disorder in various degree, the immunoregulation of the Radix Astragali can alleviate the pathology damage of nerve cell due to infarct acute stage immune response.The researchs such as Wang Hongmei show, astragalus injection can obviously increase T TCS and the TH cell number of tumor-bearing mice, in body, injection can also promote T lymphopoiesis and the conversion of ConA induction, and can also significantly improve IL-2, the TNF-α of immunosuppressed mice and the level that induces of IFN-γ.Cai little Yan finds under study for action, and the Radix Astragali has increased hormone and immunodepressant to a certain extent to the apoptotic inhibitory action of SLE patient, and regulate t lymphocyte subset group ratio and functional trend normal.In addition, research discovery, oral administration astragalus can obviously improve IgG1, IgG3 in IgG Subclass Deficiency infant serum.At random 80 routine infants are divided into oral group of astragalus liquid oral group (hormone+Radix Astragali) and hormone, after 6 months and 1 year, survey respectively infant serum, find that astragalus liquid group infant IgG obviously raises.In addition, cell factor has all played important regulating action in cellular immunity and humoral immunity.The Radix Astragali can make solubility IL-2 acceptor (sIL-2R) level in the cleer and peaceful urine of Children Patients with Simple Nephrotic Syndrome reduce.
The fruit of glossy privet (Ligustri Lucidi Fructus) is is the dry mature fruit of Oleaceae Ligustrum plant glossy privet Ligustrum Lucidum Ait..Begin to be loaded in Shennong's Herbal, classify as top grade, " bitter is flat, main bowl spares, five viscera settling, supports spirit, except all kinds of diseases and ailments ".Cool in nature, taste is sweet, bitter, returns liver, kidney channel.Tool is nourishing liver and kidney, black function of improving eyesight.Modern pharmacological research shows: to non-specific cell, immunity has humidification to the fruit of glossy privet, and the specific cellular immunity of normal mouse is had no significant effect.There is the phagocytic function that promotes lymphocytic propagation, strengthens macrophage; and have synergy with interleukin 2, thereby the rising of the micronuclei in mice cell number that endoxan and urethane are caused all can obviously suppress the damage of cell chromosome to play certain protective role.
Research finds that fruit of glossy privet decoction 0.02ml can obviously increase the lymphopoiesis that suboptimal dose phytohemagglutin phytolectin (P H A), concanavalin A (C0n A) and dyers' grapes (PWM) cause in vitro, also increase significantly the rat local graft versus host reaction that xenogenesis (people) lymphocyte causes, the effect of this enhancing immunity may be due to partly by eliminating or weakening that the effect of suppressor T lymphocyte realizes.Give the lymphocyte that causes the rat intracutaneous injection process fruit of glossy privet processing of immunosuppressive condition with Cy, the reaction of result rat local immunity improves 3-4.5 times than injection without the human lymphocyte of fruit of glossy privet processing.Lumbar injection fruit of glossy privet decoction 2.5g/kg, 25g/kg, be used in conjunction 7 days, can increase the relative molecular mass of mouse immune organ thymus gland, spleen, improves Hemolysin activity, rising normal serum IgG content; Fruit of glossy privet 240mg/kg, 480mg/kg, be used in conjunction 7 days, CS7BE mouse immune organ thymus gland, spleen, lymphonodi coeliaci, adrenal relative molecular mass can be obviously increased, the activate the phagocytic capacity of cleaning up index, enhancing reticuloendothelial system of mouse to intravenous injection carbon granules can be significantly improved.The fruit of glossy privet can make total E rosette percentage (EaRFC%) increase, promote T cell replying low dosage P H A, and the rate that increases that cpm value increases rate and EaRFC% is proportionate, showing that the fruit of glossy privet promotes the activity of T cell by strengthening the activity of cell surface receptor, may be good immunomodifier for the immunologic hypofunction disease fruit of glossy privet causing because of TS hyperactivity.Fruit of glossy privet decoction has facilitation for the delayed hypersensitive reaction due to SRBC.The research of Lee's phosphorus finds that Fructus Ligustri Lucidi polysaccharide can improve tumor-bearing mice bone-marrow-derived lymphocyte, the lymphocytic multiplication capacity of T, improves the activity of its NK cell, increases the activity of tumor-bearing mice mononuclear macrophage.Ruan Hong finds that the spleen T lymphopoiesis of the deficiency of Yin mouse of Fructus Ligustri Lucidi polysaccharide to normal mouse and cortex hormone of aadrenaline moulding has remarkable facilitation.The blue or green experimental result of hippology shows that Fructus Ligustri Lucidi polysaccharide is external to the effect of stimulating proliferation of normal mouse spleen lymphocyte, the i.e. effect of mitogen sample; To athymia, also have breeder reaction without the nude mice SPL of T cell, illustrate that Fructus Ligustri Lucidi polysaccharide has to spleen B cell the effect of directly stimulating proliferation; With nylon hair post separation T, B cell, also there is breeder reaction by the cell (being wherein rich in T cell) of nylon hair post to Fructus Ligustri Lucidi polysaccharide in result, illustrates that Fructus Ligustri Lucidi polysaccharide also has certain effect of stimulating proliferation to splenic t-cell; And normal Balb/c mouse spleen lymphocyte and nude mice SPL are under the effect of same concentrations Fructus Ligustri Lucidi polysaccharide, the former proliferation function is significantly higher than the latter, illustrate that Fructus Ligustri Lucidi polysaccharide, in acting on B cell, also has effect to T cell, or promote the interaction between the two.Wu Xifeng has observed the impact that normal mouse and endoxan is caused to immunologic hypofunction immune function of mice with glossy privet fruit extract gastric infusion.Result shows, glossy privet fruit extract (ENZZ) without impact, but can obviously increase immunosuppressed mice immune organ weight to normal Mouse Weight and immune organ weight, and can suppress the reduction of its body weight, is dose dependent.Meanwhile, ENZZ has the increase Function of lymphocyte transform of dose dependent, and high dose group is more obvious to normal mouse and immunosuppressed mice increasing action, with normal and relatively P<0.05 and P<0.01 of model control group.ENZZ has significant increasing action to the macrophage phagocytic function of normal mouse and immunologic hypofunction mouse, has obvious dosage correlation.Sun Yan finds that Aqueous Extract of Ligustrum Lucidum significantly increases suboptimal dose PHA, ConA and the short human peripheral lymphocyte splitting action of PWM; Feng Zuohua finds that Aqueous Extract of Ligustrum Lucidum is without directly urging human peripheral lymphocyte mitotic activity, but can significantly increase the short lymphocytic cell division effect of suboptimal dose PHA.Its effect is to get by the fruit of glossy privet water extraction IL-1 that induces the monocyte being mingled in lymphocyte to produce to mediate.
American Ginseng (Panacis Quinquefolii Radix) is the dry root of Araliaceae American Ginseng Ranax quinque folium L., generic name precious medicinal material.Sweet, cold in nature, the micro-hardship of its taste, returns lung, the heart, kidney, the spleen channel, has the effect of " beneficial lung yin, the clear fire of deficiency type, promotes the production of body fluid to quench thirst ".American Ginseng has BA widely, and main active ingredient is compound and the trace elements such as Radix Panacis Quinquefolii polysaccharide, saponin, can act on panimmunity competent cell, promotes the secretion of some cell factor further to bring into play immunoregulation effect.For clinical enhancing immunity, antifatigue, anti-ageing, anticancer excellent tonic product.
The immunological enhancement of American Ginseng, depends primarily on its contained active component.Wherein Radix Panacis Quinquefolii polysaccharide is that in American Ginseng, content is maximum, the class material that immunocompetence is stronger, and American Ginseng total reducing sugar content accounts for greatly 50%~65%.Research shows 200, under 400mg/kgBW dosage, Radix Panacis Quinquefolii polysaccharide (PPQ) can reduce by lower thymus gland, the spleen weight of antagonism endoxan (CY) effect, strengthens normally and the phagocytic function of immunocompromised mouse reticuloendothelial system.PPQ can increase nospecific immunity and the cellular immune function of mouse, and its immunological enhancement strengthens with dosage.PPQ can make the interior free calcium ions of T lymphocyte of activation increase simultaneously, thereby promotes lymphopoiesis differentiation, and 1L-2 produces, promotion cytotoxic T cell killing activity, thus bring into play its immunological enhancement.American ginseng saponin (PQS) is the another main active ingredient in American Ginseng, and it has obvious humidification to T, bone-marrow-derived lymphocyte function.The delayed allergy of American Ginseng Experiments of Chinese Herbal Compound on Mice, the antibody titer of serum hemolysin, macrophage phagocytic ability, splenic lymphocytes, serum lysozyme content has raising effect in various degree, and body is had to immunological enhancement.American ginseng root polysaccharide 100,200 for Li Yan etc., 400mg/kg3 dosage every day is to mouse stomach administration 1 time, the impact of observation American ginseng root polysaccharide on immunologic function.Result American ginseng root polysaccharide can not only resist alleviating of the minimizing of immunosuppressed mice PBL, Thymus and spleen weight, and can strengthen the phagocytic function of normal and immunosuppressed mice reticuloendothelial system; Obviously Promote immunity suppresses mouse spleen lymphocyte conversion, and improves activity of interleukin-2.Panax quinquefolium saponin for Yang Chunlong etc. (1mg~2mg/20g/ days) is given continuous seven days abdominal part hypodermics of mouse, the impact of research total panaquilon (PNS) on immune function of mice, found that PNS can work in coordination with in vivo and in vitro ConA and promote mouse boosting cell propagation; Collaborative ConA strengthens the ability of mouse splenic t-cell generation lymphokine; Obviously strengthen mice spleen NKC activity; PNS can also strengthen LPS in vivo stimulates the breeder reaction of mouse boosting cell; Strengthen the primary antibody response ability of mouse to thymus dependent antigen.
Radix Glycyrrhizae (Clycyrrhizae Radix Et Rhizoma) is the dry root root and rhizome of glycyrrhizic legume Clycyrrhiza uralensis Fisch., glycyrrhiza inflate bat Clycyrrhiza inflata Bat. or glycyrrhiza glabra Clycyrrhiza glabra L..Begin to be loaded in Shennong's Herbal, classify as top grade.Nature and flavor are sweet, flat, and the thoughts of returning home, lung, spleen, stomach warp, have and invigorate the spleen and benefit qi, moisten the lung and relieve the cough, relieving asthma, reduce phlegm and the effect of cortex hormone of aadrenaline sample, energy anti-inflammatory, anti-ageing, coordinating the drug actions of a prescription, current 12 warps.
The glycyrrhizin that Radix Glycyrrhizae contains can make mouse thymus gland obviously increase, and to total white blood cells, especially neutrophilia and monocyte number is obviously increased.Increase the activity of reticuloendothelial system; Under stress situation, can obviously strengthen the phagocytosis of Turnover of Mouse Peritoneal Macrophages.Polysaccharides LH in Radix Glycyrrhizae acts on T lymphocyte, presents immunologic enhancement.Experiment, to mouse glycyrrhizin totally 4 days, is then got its spleen and thymus gland and is weighed, and finds that the spleen of administration group mouse and the weight of thymus gland are apparently higher than control group.Show that glycyrrhizin can make murine interleukin sum, especially neutrophil leucocyte and monocyte number obviously increase simultaneously.Someone divides into groups to mouse stomach by 25mg/kg and 50mg/kg dosage with licorzinc, continuously after 28d, the antibody growing amount of finding 50mg/kg group significantly increases, also can make Aged Mice thymic weight obviously increase, show that humoral immunity and the cellular immune function of licorzinc to Aged Mice has facilitation.Zheng Yao etc. adopt gavage and intraperitoneal injection with licorice polysaccharide oral formulations, respectively establish three dosage groups, are respectively 1g/kg, 0.5g/kg, 0.25g/kg, continuous 10 days once a day, observe the impact of licorice polysaccharide on mouse nospecific immunity systemic-function.Result and Normal group comparison, oral formulations high dose group has significant difference (P < 0.05), and high, the middle dosage group of ejection preparation has significant difference (P < 0.01); With the comparison of lentinan group, high, the middle dosage group of ejection preparation has significant difference (P≤0.01).Visible licorice polysaccharide can improve mouse reticuloendothelial system function, not only specific immune function is had to facilitation, and non-specific immune function is also had to humidification.Cheng Anwei etc. carry out the culture experiment of lymphocytes in vitro, it is the nutrient solution of 10,100,200,400,600,800 μ g/ml containing GPS final concentration that administration group adds respectively 100 μ l/ holes, result interpolation licorice polysaccharide can obviously strengthen the secretory volume (P < 0.01) of lymphocytic energetic supersession level and 1L-2, show that licorice polysaccharide can induce activated lymphocyte, the secretion that improves its energetic supersession level and 1L-2, has immunoregulation effect.Min waits quietly using licorice polysaccharide 100mg.kg-1,200mg.kg-1,300mg.kg-1 dosage to mouse stomach 14d, and to DTH, reaction has certain humidification, IL-2, TNF-alpha content in the blood that can raise to result licorice polysaccharide; Show that licorice polysaccharide can obviously strengthen mouse cell immunologic function.
To sum up, by 4 above-mentioned taste food and medicament dual-purpose medicinal materials according to after set weight proportion, when different component has drug effect concurrently, also other components are had to complementary effect, the organic cooperation of each component, supports mutually, fruit of glossy privet tonifying liver kidney yin, bowl spares gas in the Radix Astragali, above two tastes are main ingredient.American Ginseng boosting qi and nourishing yin, wants supplement and not dry, is ministerial drug in side; Its performance emergency of Radix Glycyrrhizae; All medicines share, and energy boosting qi and nourishing yin is deficient for prolonged illness, deficiency of both vital energy and Yin, and particularly suitable is deficient and should not complete benefit person.This formula has the effect that improves body immunity, in side, each raw material all can be used for the formula of health food, has very high security, and the product of producing according to this formula is applicable to the crowd of hypoimmunity, can strengthen body immunity function, and almost be free from side effects.
Optionally, the formulation of described health food is powder.
A preparation method for above-mentioned health food, comprises the following steps:
After the Radix Astragali of set parts by weight, the fruit of glossy privet, American Ginseng, Radix Glycyrrhizae are mixed, pulverize, obtain mixed powder;
After described mixed powder adds water, decoct the scheduled time, obtain solid-liquid admixing medical solutions;
By described solid-liquid admixing medical solutions Separation of Solid and Liquid, obtain liquid;
Described liquid, successively by concentrated, dry, is obtained to health food.
Optionally, described, the Radix Astragali of set parts by weight, the fruit of glossy privet, American Ginseng, Radix Glycyrrhizae are mixed to rear pulverizing, obtain in the step of mixed powder:
The particle diameter of described mixed powder is 1.5-3 centimetre.
Optionally, after described mixed powder adds water, decoct the scheduled time, obtain, in the step of solid-liquid admixing medical solutions, specifically comprising:
In described mixed powder, adding weight is described mixed powder 6-12 water doubly, decocts 1-2 hour, and Separation of Solid and Liquid, obtains the first decoction liquor and the dregs of a decoction;
In the described dregs of a decoction, adding weight is described dregs of a decoction 5-10 water doubly, again decocts 0.4-1.5 hour, and Separation of Solid and Liquid, obtains the second decoction liquor;
Decoct liquid and described second by described first and decoct liquid mixing, obtain solid-liquid admixing medical solutions.
Optionally,, obtain in the step of liquid: described Separation of Solid and Liquid is specially filtration described solid-liquid admixing medical solutions Separation of Solid and Liquid described.
Optionally,, obtain in the step of liquid: described Separation of Solid and Liquid is specially centrifugal described solid-liquid admixing medical solutions Separation of Solid and Liquid described.
Optionally, in the process of described filtration, the order number of filter screen used is 200-300 order.
Optionally, described, described liquid is passed through to concentrate, be dried successively, obtain in the step of health food;
Described be dried as spraying dry.
Brief description of the drawings
Fig. 1 show that the embodiment of the present invention six provides for strengthening the preparation flow figure of health food of immunologic function.
Detailed description of the invention
Provide in the present invention for strengthening the health food of immunologic function, according to parts by weight meter, its material component comprises:
Radix Astragali 50-100 part, fruit of glossy privet 50-100 part, American Ginseng 5-50 part, Radix Glycyrrhizae 5-50 part; In addition, for the type of health food, it is preferably powder.
Below by specific embodiment, the present invention is described in further detail.
Embodiment mono-
The embodiment of the present invention provide for strengthening the health food of immunologic function, according to parts by weight meter, its material component comprises:
50 parts of the Radixs Astragali, 50 parts of the fruit of glossy privets, 5 parts of American Ginsengs, 5 parts, Radix Glycyrrhizae.
Embodiment bis-
The embodiment of the present invention provide for strengthening the health food of immunologic function, according to parts by weight meter, its material component comprises:
75 parts of the Radixs Astragali, 75 parts of the fruit of glossy privets, 25 parts of American Ginsengs, 25 parts, Radix Glycyrrhizae.
Embodiment tri-
The embodiment of the present invention provide for strengthening the health food of immunologic function, according to parts by weight meter, its material component comprises:
100 parts of the Radixs Astragali, 100 parts of the fruit of glossy privets, 50 parts of American Ginsengs, 50 parts, Radix Glycyrrhizae.
Embodiment tetra-
The embodiment of the present invention provide for strengthening the health food of immunologic function, according to parts by weight meter, its material component comprises:
100 parts of the Radixs Astragali, 100 parts of the fruit of glossy privets, 15 parts of American Ginsengs, 15 parts, Radix Glycyrrhizae.
Embodiment five
80 parts of the Radixs Astragali, 80 parts of the fruit of glossy privets, 15 parts of American Ginsengs, 15 parts, Radix Glycyrrhizae.
The above embodiment of the present invention provide for strengthening the health food of immunologic function, its Radix Astragali by set parts by weight, the fruit of glossy privet, American Ginseng and Radix Glycyrrhizae form; 4 above-mentioned taste food and medicament dual-purpose medicinal materials, according to after set weight proportion, when different component has drug effect concurrently, are also had to complementary effect to other components.The organic cooperation of each component, supports mutually; Fruit of glossy privet tonifying liver kidney yin, bowl spares gas in the Radix Astragali, above two tastes are main ingredient; American Ginseng boosting qi and nourishing yin, wants supplement and not dry, is ministerial drug in side; Its performance emergency of Radix Glycyrrhizae; All medicines share, and energy boosting qi and nourishing yin is deficient for prolonged illness, deficiency of both vital energy and Yin, and particularly suitable is deficient and should not complete benefit person.This formula has the effect that improves body immunity, in side, each raw material all can be used for the formula of health food, has very high security, and the product of producing according to this formula is applicable to the crowd of hypoimmunity, can strengthen body immunity function, and almost be free from side effects.
For the health food for strengthening immunologic function that makes the above embodiment of the present invention is better applied, more effectively apply in the field of health food, the present invention also provides the preparation method of health food on the basis of above-described embodiment, is now described in detail and explains:
Embodiment six
The preparation method that the embodiment of the present invention provides comprises the following steps:
Step 101: pulverize after the Radix Astragali of set parts by weight, the fruit of glossy privet, American Ginseng, Radix Glycyrrhizae are mixed, obtain mixed powder;
In step 101, in the process of pulverizing after the Radix Astragali, the fruit of glossy privet, American Ginseng, Radix Glycyrrhizae are mixed, preferably its pulverizing is obtained to thinner particle (making the active ingredient of health food obtain discharging comparatively completely), preferred, the particle diameter of described mixed powder is 1.5-3 centimetre.
Step 102: decoct the scheduled time after described mixed powder adds water, obtain solid-liquid admixing medical solutions;
Concrete, decocting sufficient effect in order to realize, above-mentioned steps is carried out according to following operation: in described mixed powder, adding weight is described mixed powder 6-12 water doubly, decocts 1-2 hour, and Separation of Solid and Liquid, obtains the first decoction liquor and the dregs of a decoction;
In the described dregs of a decoction, adding weight is described dregs of a decoction 5-10 water doubly, again decocts 0.4-1.5 hour, and Separation of Solid and Liquid, obtains the second decoction liquor;
Decoct liquid and described second by described first and decoct liquid mixing, obtain solid-liquid admixing medical solutions.
By adding after the water of set weight carries out twice decoction, obtain solid-liquid admixing medical solutions, its drug effect extracts active ingredients is complete, the drug effect of the health food made to help raising.
Step 103: by described solid-liquid admixing medical solutions Separation of Solid and Liquid, obtain liquid;
Concrete, the mode of Separation of Solid and Liquid can be taked mode centrifugal or that filter, and in the time adopting filter operation, preferred, the order number of filter screen used is 200-300 order.
Step 104: described liquid, successively by concentrated, dry, is obtained to health food.
In dry process, preferably make the liquid pulverize powder health food after concentrated by spray-dired mode.
In addition, the health food that the present invention also provides for embodiment tetra-and five has provided concrete preparation example (being designated as respectively preparation example one and preparation example two)
Preparation example one
A kind of for strengthening the health food of immunologic function, according to listed as parts by weight, made by 15 parts of 100 parts of the Radixs Astragali, 100 parts of the fruit of glossy privets, 15 parts of American Ginsengs, Radix Glycyrrhizae, production method comprises the steps: first to select that the Radix Astragali, the fruit of glossy privet, American Ginseng, the Radix Glycyrrhizae of dried and clean pulverize, and makes material particular diameter after pulverizing in 2cm left and right; After weighing, mix, subsequently mixed material is mixed with the weight ratio of 1: 10 with water, boil, then keeping micro-boils 1 hour, then filter and obtain the first decoction liquor, will expect that slag mixes with the weight ratio of 1: 8 with water, boils subsequently, then keep micro-and boil 40 minutes, subsequently after filtration or centrifugal second decoction liquor that obtains; By after the first decoction liquor and the merging of the second decoction liquor, be condensed into medicinal extract, be dried successively, pulverize, obtain Powdered health food.
Preparation example two
A kind of for strengthening the health food of immunologic function, according to weight portion meter, be made up of 15 parts of 80 parts of the Radixs Astragali, 80 parts of the fruit of glossy privets, 15 parts of American Ginsengs, Radix Glycyrrhizae, production method comprises the steps: first to select the Radix Astragali, the fruit of glossy privet, American Ginseng, the Radix Glycyrrhizae four taste health foods of dried and clean; After weighing, mix, subsequently mixed material is mixed with the weight ratio of 1: 8 with water, boil, then keeping micro-boils 1.5 hours, then filter and obtain the first decoction liquor, will expect that slag mixes with the weight ratio of 1: 6 with water, boils subsequently, then keep micro-and boil 1 hour, subsequently after filtration or centrifugal second decoction liquor that obtains; The first decoction liquor and the second decoction liquor are merged to rear concentrating, then be spray dried to powder.
In addition, the present invention also provides the animal immune experiment research that above-described embodiment provides five health food:
Animal used as test and grouping: the healthy Male Kunming strain mice of SPF level, body weight 18~22g.Every 40 mouse are one group, totally 6 groups.Immunity I group, the mouse spleen lymphocyte transformation experiment that carries out ConA induction; Immunity II group, carries out delayed allergy experiment; Immunity III group, carries out dirty/body ratio measurement, and serum hemolysin is measured and antibody-producting cell number is measured; Immunity IV~VI group, carries out respectively that carbon is cleaned up experiment, peritoneal macrophage is engulfed chicken red blood cell and tested and NK cytoactive detection.If a negative control group, 10 every group.
Dosage is selected to give mode with tested material: according to the oral recommendation consumption of people, establish that basic, normal, high dosage group is respectively 2.7,5.4,10.8mg/kg BW.Powdered health food dissolves with pure water, gives respectively corresponding dosage treated animal gavage.Negative control group gives isopyknic pure water.Every day gavage 1 time, continuously gavage 30 days.
Experimental technique and result:
1, the impact of sample on Mouse Weight
Table 1 Mouse Weight
Note: the experiment of each dosage group is initial, the weightening finish of Mice Body restatement and control group comparison in mid-term and latter stage, and there are no significant for difference (P>0.05).
From table 1, oral administration gives the sample 30 days of mouse various dose, Mouse Weight and duration of test weight of mice value and the negative control group comparison of experiment initial stage, experiment mid-term, test sample in latter stage each dosage group, no significant difference (P>0.05), shows that this sample has no significant effect the body weight gain of mouse.
2, the impact of sample on mouse immune organ internal organs/body weight ratio:
Table 2 mouse immune organ internal organs/body weight ratio
From table 2, thymus gland/body weight of the each dosage group of sample mouse and spleen/body weight ratio and negative control group comparison, difference that there are no significant (P>0.05), shows that sample has no significant effect the immune organ weight of mouse.
3, the impact (mtt assay) of the mouse spleen lymphocyte conversion capability of sample on ConA induction
Table 3 mouse lymphocyte transformation experiment result
From table 3, the lymphocyte proliferation ability of the each dosage group of sample mouse is higher than negative control group, and the difference of high dose group and negative control group has conspicuousness (P<0.05), show that sample has the lymphocyte proliferation of promotion mouse, the effect of conversion capability.
4, the impact (ear swelling method) of sample on mouse delayed allergy DTH
Table 4 mouse delayed allergy DTH experimental result
From table 4, the left and right auricle weight difference of the each dosage group of sample mouse is higher than negative control group, and the difference of height, middle dosage group and negative control group has very significant (P<0.01), show that sample has the effect of the delayed allergy that promotes mouse.
5, the impact of the antibody-producting cell number of sample on mouse (Jerne improves slide method)
Table 5 mouse antibodies cellulation test experience result
From table 5, the antibody-producting cell number of the each dosage group of sample mouse is higher than negative control group, and the difference of high dose group and negative control group has very significant (P<0.01), show that sample has the value-added effect of antibody-producting cell that promotes mouse.
6, the impact (Hemagglutination Method) of sample on mice serum hemolysin
Table 6 mouse hemolysin test result
From table 6, the antibody product of the each dosage group of sample mouse is higher than negative control group, and the difference of high dose group and negative control group has conspicuousness (P<0.05), show that sample has the effect of the serum hemolysin that improves mouse.
7, the impact (carbon is cleaned up experiment) that sample is cleaned up the monocytes/macrophages carbon of mouse
Table 7 mouse monokaryon-macrophage carbon is cleaned up experimental result
From table 7, phagocytic index and the negative control group comparison of the monocytes/macrophages of the each dosage group of sample mouse, there was no significant difference tool (P>0.05), shows that sample cleans up function without obvious facilitation to the monocytes/macrophages carbon of mouse.
8, sample is engulfed the impact (half intracorporal method) of chicken red blood cell ability on the peritoneal macrophage of mouse
Table 8 Turnover of Mouse Peritoneal Macrophages is engulfed chicken red blood cell experimental result
From table 8, the phagocytic rate of the peritoneal macrophage of the each dosage group of sample mouse to chicken red blood cell and phagocytic index are higher than negative control group, wherein the phagocytic rate of high dose group and the difference of negative control group have very significant (P<0.01), the phagocytic index of high, middle dosage group and the difference of negative control group have conspicuousness (P<0.01 and P<0.05 respectively), show that sample has the effect of the phagocytic function of the peritoneal macrophage that promotes mouse.
9, the impact (LDH determination method) of the NK cytoactive of sample on mouse
Table 9 NK cells in mice determination of activity result
From table 9, the NK cytoactive of the each dosage group of sample mouse is higher than negative control group, but there are no significant (P>0.05) for the difference of each dosage group and negative control group, show that sample obviously affects the NK cytoactive thing of mouse.
Known by the above-mentioned experiment for mouse, what the embodiment of the present invention provided is this for strengthening the health food of immunologic function, there is the effect that improves people's immunity, in side, each raw material all can be used for the formula of health food, there is very high security, the product of producing according to this formula is applicable to the crowd of hypoimmunity, can strengthen body immunity function.
Finally, it is pointed out that this health food that the above-mentioned all embodiment of the present invention provide, it can not eaten or be taken as final products.For example, it can be used as that raw material mixes with other auxiliary materials and for making health food or the medicine etc. with immunoenhancement result of other types the health food that above-mentioned all embodiment provide.
The foregoing is only the preferred embodiments of the present invention, be not limited to the present invention, for a person skilled in the art, the present invention can have various modifications and variations.Within the spirit and principles in the present invention all, any amendment of doing, be equal to replacement, improvement etc., within all should being included in protection scope of the present invention.
Claims (9)
1. for strengthening a health food for immunologic function, it is characterized in that, according to weighing scale, its raw material components comprises:
Radix Astragali 50-100 part, fruit of glossy privet 50-100 part, American Ginseng 5-50 part, Radix Glycyrrhizae 5-50 part.
2. health food according to claim 1 and 2, is characterized in that, the formulation of described health food is powder.
3. a preparation method for health food according to claim 1, is characterized in that, comprises the following steps:
After the Radix Astragali of set parts by weight, the fruit of glossy privet, American Ginseng, Radix Glycyrrhizae are mixed, pulverize, obtain mixed powder;
After described mixed powder adds water, decoct the scheduled time, obtain solid-liquid admixing medical solutions;
By described solid-liquid admixing medical solutions Separation of Solid and Liquid, obtain liquid;
Described liquid, successively by concentrated, dry, is obtained to health food.
4. the preparation method of health food according to claim 3, is characterized in that, described, the Radix Astragali of set parts by weight, the fruit of glossy privet, American Ginseng, Radix Glycyrrhizae is mixed to rear pulverizing, obtains in the step of mixed powder:
The particle diameter of described mixed powder is 1.5-3 centimetre.
5. the preparation method of health food according to claim 3, is characterized in that, after described mixed powder adds water, decocts the scheduled time, obtains, in the step of solid-liquid admixing medical solutions, specifically comprising:
In described mixed powder, adding weight is described mixed powder 6-12 water doubly, decocts 1-2 hour, and Separation of Solid and Liquid, obtains the first decoction liquor and the dregs of a decoction;
In the described dregs of a decoction, adding weight is described dregs of a decoction 5-10 water doubly, again decocts 0.4-1.5 hour, and Separation of Solid and Liquid, obtains the second decoction liquor;
Decoct liquid and described second by described first and decoct liquid mixing, obtain solid-liquid admixing medical solutions.
6. the preparation method of health food according to claim 3, is characterized in that,, obtains in the step of liquid: described Separation of Solid and Liquid is specially filtration described solid-liquid admixing medical solutions Separation of Solid and Liquid described.
7. the preparation method of health food according to claim 3, is characterized in that,, obtains in the step of liquid: described Separation of Solid and Liquid is specially centrifugal described solid-liquid admixing medical solutions Separation of Solid and Liquid described.
8. the preparation method of health food according to claim 6, is characterized in that, in the process of described filtration, the order number of filter screen used is 200-300 order.
9. the preparation method of health food according to claim 3, is characterized in that, described, described liquid is passed through to concentrate, be dried successively, obtains in the step of health food;
Described be dried as spraying dry.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410203602.7A CN103960663A (en) | 2014-05-14 | 2014-05-14 | Health care food for enhancing immunologic function and preparation method of food |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410203602.7A CN103960663A (en) | 2014-05-14 | 2014-05-14 | Health care food for enhancing immunologic function and preparation method of food |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103960663A true CN103960663A (en) | 2014-08-06 |
Family
ID=51231069
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410203602.7A Pending CN103960663A (en) | 2014-05-14 | 2014-05-14 | Health care food for enhancing immunologic function and preparation method of food |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103960663A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106387867A (en) * | 2016-08-27 | 2017-02-15 | 桂林七星粉业有限责任公司 | Processing technology of tartarian buckwheat health-care capsules having effect of reducing blood sugar |
CN106581175A (en) * | 2017-03-13 | 2017-04-26 | 孙燕 | Traditional Chinese medicine composition having effect of inhibiting tumor-related cytokines and use thereof |
CN114681586A (en) * | 2020-12-25 | 2022-07-01 | 黑龙江省儒中医疗科技有限公司 | Influenza external vaccine and preparation method thereof |
CN116763812A (en) * | 2023-08-17 | 2023-09-19 | 青岛农业大学 | American ginseng polysaccharide, osteoporosis treatment medicine prepared from American ginseng polysaccharide and application of American ginseng polysaccharide |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1362170A (en) * | 2001-01-02 | 2002-08-07 | 杨孟君 | Nano body resistance-strengthening Zhenqi medicine and its preparation |
WO2003101389A2 (en) * | 2002-05-29 | 2003-12-11 | Bio-Defense Nutritionals | Relief of aids symptoms |
CN101385772A (en) * | 2008-01-09 | 2009-03-18 | 姜宝库 | Effervescence tablets for increasing natural immunity |
CN102772573A (en) * | 2012-08-10 | 2012-11-14 | 广东太阳神集团有限公司 | Oral liquid for strengthening immunity and resisting virus and preparation method thereof |
-
2014
- 2014-05-14 CN CN201410203602.7A patent/CN103960663A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1362170A (en) * | 2001-01-02 | 2002-08-07 | 杨孟君 | Nano body resistance-strengthening Zhenqi medicine and its preparation |
WO2003101389A2 (en) * | 2002-05-29 | 2003-12-11 | Bio-Defense Nutritionals | Relief of aids symptoms |
CN101385772A (en) * | 2008-01-09 | 2009-03-18 | 姜宝库 | Effervescence tablets for increasing natural immunity |
CN102772573A (en) * | 2012-08-10 | 2012-11-14 | 广东太阳神集团有限公司 | Oral liquid for strengthening immunity and resisting virus and preparation method thereof |
Non-Patent Citations (1)
Title |
---|
无: "黄芪女贞子西洋参煮水提高免疫力《内外兼攻 克癌有道-2》", 《HTTP://BLOG.SINA.COM.CN/S/BLOG_59DCCED90102ED31.HTML》, 14 October 2013 (2013-10-14), pages 1 - 4 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106387867A (en) * | 2016-08-27 | 2017-02-15 | 桂林七星粉业有限责任公司 | Processing technology of tartarian buckwheat health-care capsules having effect of reducing blood sugar |
CN106581175A (en) * | 2017-03-13 | 2017-04-26 | 孙燕 | Traditional Chinese medicine composition having effect of inhibiting tumor-related cytokines and use thereof |
CN106581175B (en) * | 2017-03-13 | 2021-03-02 | 孙燕 | Traditional Chinese medicine composition capable of inhibiting tumor-related cytokines and application thereof |
CN114681586A (en) * | 2020-12-25 | 2022-07-01 | 黑龙江省儒中医疗科技有限公司 | Influenza external vaccine and preparation method thereof |
CN116763812A (en) * | 2023-08-17 | 2023-09-19 | 青岛农业大学 | American ginseng polysaccharide, osteoporosis treatment medicine prepared from American ginseng polysaccharide and application of American ginseng polysaccharide |
CN116763812B (en) * | 2023-08-17 | 2023-11-03 | 青岛农业大学 | American ginseng polysaccharide, osteoporosis treatment medicine prepared from American ginseng polysaccharide and application of American ginseng polysaccharide |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1762236B (en) | Health-caring product capable of increasing human immunity and its preparation method | |
CN104435749B (en) | A kind of dendrobium candidum compound preparation and its preparation method and application | |
CN104435748A (en) | Dendrobium officinale compound preparation as well as preparation method and application of dendrobium officinale compound preparation | |
CN101816739B (en) | Chinese medicinal composition and preparation method thereof | |
CN104666892A (en) | Sealwort and ginseng formula for enhancing immunity and relieving fatigue and preparation method of formula | |
CN103520577A (en) | Medicine-and-food dual-purpose preparation for treating pneumoconiosis, clearing away lung-heat and nourishing heart and preparation method for medicine-and-food dual-purpose preparation | |
CN101181351B (en) | Chinese medicine composition for resisting tiredness and reinforcing immune as well as method of making the same | |
CN103053733A (en) | Oriental beauty tea with the functions of adjusting the vitality and nourishing the blood, improving microcirculation and tendering skin and beauty and preparation method thereof | |
CN103960663A (en) | Health care food for enhancing immunologic function and preparation method of food | |
CN110893197B (en) | Panax notoginseng extract for treating gout and preparation method thereof | |
CN102228252A (en) | Application of Chinese medicinal composition in preparation of healthcare foods and medicines for improving hypoxia tolerance | |
CN103155985B (en) | Rhizoma polygonati nutrition powder and preparation method thereof | |
CN106177053A (en) | A kind of Hyperglycemic health care compositions comprising leaf of Cyclocarya paliurus Iljinskaja and Pericarpium Citri Reticulatae | |
CN102600368A (en) | Pharmaceutical composition, as well as preparation method and application thereof | |
CN102631494B (en) | Traditional Chinese medicine composition capable of improving immunity and resisting fatigue | |
CN107836619A (en) | A kind of beautiful millettia root solid beverage with strengthen immunity and antifatigue effect and preparation method thereof | |
CN101810337A (en) | Health food containing pseudo-ginseng and ganoderma lucidum and radix astragali | |
CN101829246A (en) | Transdermal infusion paste preparation for enhancing immunity and preparation method thereof | |
US20190038708A1 (en) | Medicament for use in treating fatty liver, hepatitis and cirrhosis | |
CN105687480A (en) | Immunoregulatory traditional Chinese medicine composition and preparation | |
CN106075056A (en) | A kind of Ganoderma lucidum and preparation method improving immunity and improving gastrointestinal function | |
CN104056054A (en) | Antioxidant and immunity-improving oral preparation and preparation method for same | |
CN108567854A (en) | Join Ling oral liquid and preparation method thereof | |
CN102641402A (en) | Preparation and quality control method of traditional Chinese medicine compound preparation for treating nephritis | |
CN105796819A (en) | Immunomodulating selenium-rich Chinese herbal medicine composition containing compound polysaccharide and preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140806 |